TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 1 | -2 | -7 | -9 | -1 | 8 | 48 | 6 |
| S | %wins | 100 | 100 | 100 | 100 | 0 | 0 | 67 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/14/12 17:33 | 5/10/12 | VRX | Valeant Pharmaceuticals International, Inc. | A6 | Health | Drug | Pharmaceutical Preparations | Masterson Richard Kevin | A8 | O | P,COO,Va | S | 0 | 52.57 | 33 | 0 | 0 | 90 | D | 239 | 2 | 28 | 10 | -1 | -4 | -6 | 2 | -2 | -7 | -9 | -1 | 8 | 48 |
4/16/12 20:47 | 4/12/12 | VRX | Valeant Pharmaceuticals International, Inc. | A6 | Health | Drug | Pharmaceutical Preparations | Masterson Richard Kevin | A8 | O | P,COO,Va | M.d | 0 | 0.00 | 33 | 6 | 7 | 90 | D | 229 | 0 | 48 | 7 | -2 | -2 | -3 | 0 | 2 | 2 | -5 | -16 | 4 | 36 |
8/15/11 18:47 | 8/11/11 | VRX | Valeant Pharmaceuticals International, Inc. | A6 | Health | Drug | Pharmaceutical Preparations | Masterson Richard Kevin | A6 | O | P,COO,Va | M.d | 400 | 9.42 | 33 | 42 | 65 | 108 | D | 212 | 87 | -1 | -20 | -23 | -28 | -23 | 0 | 0 | -1 | -1 | 3 | 21 | 25 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |